Patent details

EP1225870 Title: COMPOSITION AND METHOD OF CANCER ANTIGEN IMMUNOTHERAPY

Basic Information

Publication number:
EP1225870
PCT Application Number:
PCT/US/2000/027399
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009686924
PCT Publication Number:
WO/2001/024771
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITION AND METHOD OF CANCER ANTIGEN IMMUNOTHERAPY
French Title of Invention:
COMPOSITION ET METHODE D'IMMUNOTHERAPIE ANTIGENIQUE ANTICANCEREUSE
German Title of Invention:
ZUSAMMENSETZUNG UND VERFAHREN ZUR KREBS-ANTIGEN-IMMUNTHERAPIE
SPC Number:

Dates

Filing date:
05/10/2000
Grant date:
27/12/2006
EP Publication Date:
27/12/2006
PCT Publication Date:
12/04/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/07/2002
EP B1 Publication Date:
27/12/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/10/2008
Expiration date:
05/10/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/10/2000
 
 

Name:
TVAX Biomedical LLC
Address:
500 West 112th Street, Kansas, MO 64114, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
28/03/2007
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Wood Gary W.
Address:
United States (US)

Priority

Priority Number:
412681
Priority Date:
05/10/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/00;
Filing date Document type Number of pages